Increased serum asprosin is correlated with diabetes mellitus-induced erectile dysfunction

Table 4 Correlation of circulating asprosin, MDA, SOD with IIEF-5 score in all subjects

Independent variable	Models	β	95%confidence interval	P
Asprosin	Model1	-2.84	-3.53 to -2.16	p < 0.001
	Model2	-2.83	-3.53 to-2.13	p < 0.001
	Model3	-2.21	-3.01 to -1.40	p < 0.001
	Model4	-2.29	-3.17 to -1.42	p < 0.001
MDA	Model1	-3.35	-4.21 to -2.50	p < 0.001
	Model2	-3.33	-4.20 to -2.46	p < 0.001
	Model3	-2.28	-3.23to -1.33	p < 0.001
	Model4	-2.23	-3.35to -1.30	p < 0.001
SOD	Model1	0.19	0.14 to 0.23	p < 0.001
	Model2	0.18	0.14 to 0.23	p < 0.001
	Model3	0.12	0.58 to 0.19	p < 0.001
	Model4	0.13	0.06 to 0.20	p < 0.001

Model 1: crude, Model 2: adjusted for age, Model 3: Model 2 plus smoking status, duration of diabetes, Testosterone, BMI, SBP, DBP, HbA1c, TC, TG, HDL-C, LDL-C, fatty liver disease, Model 4: Model 3 plus pharmaceutic treatment(Statin, Metformin, Sulfonylureas, DPP-IVi, GLP-1RA, SGLT2i, Acarbose, Insulin, TZDs
,ACEI/ARB, CCB,β-blocker, diuretic)

ISSN: 1758-5996